Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeshima, R.
Right arrow Articles by Traystman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeshima, R.
Right arrow Articles by Traystman, R. J.

Stroke, Vol 23, 247-252, Copyright © 1992 by American Heart Association


ARTICLES

Monoclonal leukocyte antibody does not decrease the injury of transient focal cerebral ischemia in cats

R Takeshima, JR Kirsch, RC Koehler, AW Gomoll and RJ Traystman
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Md.

BACKGROUND AND PURPOSE: We tested the hypothesis that inhibition of leukocyte function by administration of monoclonal antibody 60.3 (MoAb 60.3) improves electrophysiological recovery and decreases injury volume following transient focal cerebral ischemia in cats. METHODS: Halothane-anesthetized cats underwent 90 minutes of left middle cerebral artery and bilateral common carotid artery occlusion followed by 180 minutes of reperfusion. Cats were assigned to receive either 2 mg/kg MoAb 60.3 (n = 8) directed at the CDw18 leukocyte antigen complex or an equal volume of diluent (sterile saline; n = 10) at 45 minutes of ischemia in a blinded fashion. RESULTS: Blood flow to the left temporoparietal cortex decreased to less than 5 ml/min/100 g with ischemia, but was minimally affected on the right side. Postischemic hyperemia occurred in the left caudate nucleus, whereas blood flow in other brain regions returned to control. No region demonstrated delayed hypoperfusion, and there were no differences between groups. Somatosensory evoked potential recorded over the left cortex was ablated during ischemia and recovered to less than 10% of baseline amplitude at 180 minutes of reperfusion in both groups. Left hemispheric injury volume, as assessed by 2,3,5-triphenyltetrazolium chloride staining, was not affected by drug treatment (mean +/- SE values: MoAb 60.3, 37 +/- 5%; placebo, 38 +/- 7% of hemisphere). CONCLUSIONS: Inhibition of leukocyte function with MoAb 60.3 does not afford protection from severe focal ischemia and reperfusion in cats.


This article has been cited by other articles:


Home page
StrokeHome page
S.-H. Ahmed, Y. Y. He, A. Nassief, J. Xu, X. M. Xu, C. Y. Hsu, and F. M. Faraci
Effects of Lipopolysaccharide Priming on Acute Ischemic Brain Injury Editorial Comment
Stroke, January 1, 2000; 31(1): 193 - 199.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. J. Prestigiacomo, S. C. Kim, E. S. Connolly Jr, H. Liao, S.-F. Yan, D. J. Pinsky, and G. Feuerstein
CD18-Mediated Neutrophil Recruitment Contributes to the Pathogenesis of Reperfused but Not Nonreperfused Stroke • Editorial Comment
Stroke, May 1, 1999; 30(5): 1110 - 1117.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. G. Soriano, A. Coxon, Y. F. Wang, M. P. Frosch, S. A. Lipton, P. R. Hickey, T. N. Mayadas, and P. H. Chan
Mice Deficient in Mac-1 (CD11b/CD18) Are Less Susceptible to Cerebral Ischemia/Reperfusion Injury • Editorial Comment
Stroke, January 1, 1999; 30(1): 134 - 139.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Pantoni, C. Sarti, and D. Inzitari
Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives
Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 503 - 513.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Bethel, J. R. Kirsch, R. C. Koehler, S. P. Finklestein, and R. J. Traystman
Intravenous Basic Fibroblast Growth Factor Decreases Brain Injury Resulting From Focal Ischemia in Cats
Stroke, March 1, 1997; 28(3): 609 - 616.
[Abstract] [Full Text]


Home page
StrokeHome page
H. Takahashi, J. R. Kirsch, K. Hashimoto, E. D. London, R. C. Koehler, and R. J. Traystman
PPBP [4-Phenyl-1-(4-phenylbutyl) Piperidine], a Potent {varsigma}-Receptor Ligand, Decreases Brain Injury After Transient Focal Ischemia in Cats
Stroke, September 1, 1995; 26(9): 1676 - 1682.
[Abstract] [Full Text]